{"@context":{"dc":"http:\/\/purl.org\/dc\/elements\/1.1\/","skos":"http:\/\/www.w3.org\/2004\/02\/skos\/core#","skos:broader":{"@type":"@id"},"skos:inScheme":{"@type":"@id"},"skos:related":{"@type":"@id"},"skos:narrower":{"@type":"@id"},"skos:hasTopConcept":{"@type":"@id"},"skos:topConceptOf":{"@type":"@id"}},"@id":"https:\/\/adm.senado.leg.br\/vcb\/vocab\/skos\/7381","@type":"skos:Concept","skos:prefLabel":{"@language":"pt-BR","@value=":"Coagulopatia"},"skos:inScheme":"https:\/\/adm.senado.leg.br\/vcb\/vocab\/","dct:created":"2020-09-18 17:43:27","skos:definition":[{"@lang":"ab","@value":"Perturba\u00e7\u00e3o patol\u00f3gica da coagula\u00e7\u00e3o de sangue (estados protromb\u00f3ticos e di\u00e1teses hemorr\u00e1gicas) devida a transtorno ou car\u00eancia de fatores plasm\u00e1ticos que interv\u00eam na coagula\u00e7\u00e3o.$vINFOP\u00c9DIA Porto "}],"skos:narrower":["https:\/\/adm.senado.leg.br\/vcb\/vocab\/skos\/7383"],"skos:broader":["https:\/\/adm.senado.leg.br\/vcb\/vocab\/skos\/12256"],"skos:related":["https:\/\/adm.senado.leg.br\/vcb\/vocab\/skos\/7382","https:\/\/adm.senado.leg.br\/vcb\/vocab\/skos\/2485","https:\/\/adm.senado.leg.br\/vcb\/vocab\/skos\/4777"]}